Tirzepatide Across the Cardiovascular Continuum From HFpEF to cardiorenal protection with a dual GLP-1/GIP agonist. Diabzen, [S. l.], v. 4, n. 21, p. 42–43, 2026. Disponível em: https://thediabzen.com/index.php/d/article/view/64. Acesso em: 28 jul. 2026.